Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-14,000
Closed -$291K 4542
2023
Q4
$291K Hold
14,000
﹤0.01% 3755
2023
Q3
$211K Hold
14,000
﹤0.01% 3741
2023
Q2
$186K Hold
14,000
﹤0.01% 3756
2023
Q1
$207K Sell
14,000
-81,000
-85% -$1.15M ﹤0.01% 3892
2022
Q4
$1.06M Sell
95,000
-17,500
-16% -$176K ﹤0.01% 3404
2022
Q3
$930K Buy
112,500
+46,000
+69% +$478K ﹤0.01% 3649
2022
Q2
$650K Buy
66,500
+7,500
+13% +$87.3K ﹤0.01% 3930
2022
Q1
$774K Sell
59,000
-65,520
-53% -$986K ﹤0.01% 4105
2021
Q4
$2.25M Buy
+124,520
New +$2.69M ﹤0.01% 3249

Other funds holding KD

David Shaw's KD Position: Q2 2026 in Review

David Shaw increased its Kyndryl (KD) stake by 128% in Q2 2026, buying an estimated $62M and bringing the position to 8,862,810 shares worth $100M. The position accounts for 0.05% of the portfolio, ranked #449.

David Shaw first reported a position in KD in Q4 2021 and has held it in 19 quarters since. 668 funds tracked by Wall St. Rank hold KD as of Q2 2026.

  • David Shaw held 8,862,810 shares of Kyndryl worth $100M as of Q2 2026.
  • David Shaw bought 4,979,294 Kyndryl shares in Q2 2026, an estimated $62M.
  • Kyndryl made up 0.05% of David Shaw's portfolio in Q2 2026, its #449 holding.
  • David Shaw first reported a position in Kyndryl in Q4 2021 and has held it in 19 quarters since.
  • 668 funds tracked by Wall St. Rank held Kyndryl as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.